Autism clinical trials at UCSF
4 in progress, 3 open to eligible people
AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
open to eligible people ages 5-17
The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated with autism spectrum disorder.
San Francisco, California and other locations
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
open to eligible people ages 12-45
ML-004-002 is a multi-center, randomized, double-blind, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD
San Francisco, California and other locations
Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
open to eligible people ages 6-17
This study will be conducted to evaluate the efficacy of GWP42003-P, compared with placebo, in reducing symptom severity in children with Autism Spectrum Disorder (ASD).
San Francisco, California and other locations
An Open Label Study of CM-AT for the Treatment of Children With Autism
Sorry, in progress, not accepting new patients
This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.
San Francisco, California and other locations
Our lead scientists for Autism research studies include Robert Hendren, DO.
Last updated: